SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
152Updated report, dated June 10, 2013 by Catalyst Equity Research howardgroupinc.Sultan16/12/2013
151Neptune Commences Reconstruction of Sherbrooke Plant LAVAL, Quebec, May 28, 201Sultan15/28/2013
150Neptune Technologies could come back stronger than ever, says Byron Capital’s LoSultan-5/28/2013
149Neptune Reports Fiscal 2013 Results and Provides Update on Action Plan to ResumeSultan15/22/2013
148Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sultan15/15/2013
147Class Action Lawsuit Against Neptune Dismissed LAVAL, Quebec, May 15, 2013 (GLOSultan15/15/2013
146The U.S. International Trade Commission (ITC) Votes to Institute Patent InfringSultan-4/15/2013
145Neptune Provides Update on European Patent Dispute and Maintains Its InternationSultan14/10/2013
144Dr. Waksal Provides Update On Neptune & Acasti At The Roth Conference [graSultan13/19/2013
143Acasti Pharma Presents Preliminary Data Moving Forward With Clinical Strategy LSultan-3/19/2013
142Neptune to Present at the Annual ROTH Conference LAVAL, Quebec, March 14, 2013 Sultan13/14/2013
141Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further BolsteSultan12/26/2013
140Neptune Responds to Aker BioMarine's Attempt to Shift the Focus From NeptuneSultan-1/31/2013
139Neptune Files ITC Complaint Against Competitors Aker, Enzymotec, Rimfrost, OlympSultan11/30/2013
138Speculative Quasi-Biotech Neptune Off To A Strong Start In 2013 seekingalpha.coSultan11/29/2013
137This was mailed to share holders by IR firm for Neptune.. Catalyst Report: “WeSultan11/22/2013
136Neptune on the road to recovery from Sherbrooke tragedy, says Byron cantechlettSultan11/18/2013
135Neptune Technologies & Bioresources' CEO Discusses F3Q12 Results - EarniSultan11/17/2013
134Neptune Conference Call Summary – Plant Construction Starts In March – OutsourciSultan11/17/2013
133Anticipating Neptune's Big Bounce to Continue LOS ANGELES, CA--(Marketwire Sultan11/15/2013
132Neptune Reports Third Quarter Results and Confirms First Insurance Payment LAVASultan11/15/2013
131Acasti Pharma to start trading on Nasdaq on January 7 Laval, Québec, CANADSultan11/7/2013
130This is an interesting news item in context of what Acasti Pharma is doing with Sultan-12/20/2012
129Neptune Comments on Filing of Lawsuit LAVAL, Quebec, Dec. 20, 2012 (GLOBE NEWSWSultan112/20/2012
128Smart Investors Spot Profitable Upside in Neptune's Recovery Plan LOS ANGELSultan112/19/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News